Cargando…
De novo lipogenesis is elicited dramatically in human hepatocellular carcinoma especially in hepatitis C virus‐induced hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. Abnormal de novo lipogenesis is reported to be involved in hepatocarcinogenesis. In current study, de novo lipogenesis and its association with patient survival rate were investigated in human HCC samples induced b...
Autores principales: | Li, Shaojian, Liu, Ruonan, Pan, Qinling, Wang, Genshu, Cheng, Daorou, Yang, Jie, Chen, Hui, Xu, Geyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491216/ https://www.ncbi.nlm.nih.gov/pubmed/34766116 http://dx.doi.org/10.1002/mco2.15 |
Ejemplares similares
-
Role of hepatoma‐derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma
por: Min, Xuejie, et al.
Publicado: (2018) -
Targeting De Novo Lipogenesis and Cholesterol Biosynthesis Simultaneously is a Novel Therapeutic Option for Hepatocellular Carcinoma
por: Liu, Qian, et al.
Publicado: (2021) -
High level of serum Cripto-1 in hepatocellular carcinoma, especially with hepatitis B virus infection
por: Zhang, Yingyu, et al.
Publicado: (2018) -
Dual-tracer positron emission tomography/computed tomography as an imaging probe of de novo lipogenesis in preclinical models of hepatocellular carcinoma
por: Tsao, Chin-Ho, et al.
Publicado: (2022) -
Downregulation of PDK4 Increases Lipogenesis and Associates with Poor Prognosis in Hepatocellular Carcinoma
por: Yang, Chen, et al.
Publicado: (2019)